Results 211 to 220 of about 817,567 (359)

Risk Behaviors, HIV Seropositivity, and Tuberculosis Infection in Injecting Drug Users Who Operate Shooting Galleries in Puerto Rico

open access: bronze, 1998
Rafaela R. Robles   +8 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

Immune profiling in Puerto Rican injection drug users with and without HIV-1 infection. [PDF]

open access: yesJ Leukoc Biol, 2023
Bennett SJ   +14 more
europepmc   +1 more source

Molecular Epidemiology of HTLV-II among United States Blood Donors and Intravenous Drug Users: An Age–Cohort Effect for HTLV-II RFLP Type a0

open access: bronze, 1998
Edward L. Murphy   +6 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

HIV-1 Transmission Cluster in Injection Drug Users in Nairobi City, Kenya. [PDF]

open access: yesEthiop J Health Sci, 2023
Webale SK   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy